Background: A low sodium diet is an established intervention in the treatment of impaired renal function and hypertension which may modulate cardiovascular risk independent of recognised antihypertensive effects. Epidemiological data suggest that dietary sodium intake may be associated with systemic inflammation: another potential pathophysiological mechanism by which sodium intake may modify vascular disease.
Methods: We tested the hypothesis that adopting a low sodium diet may decrease biomarkers of systemic inflammation or coagulation using data from a randomised double-blind placebo-controlled trial.
Introduction: We aimed to evaluate the role of routine measurements of serum amylase and lipase in the diagnosis of acute abdominal pain.
Patients And Methods: We identified all patients who had serum amylase and lipase assays over a 62-day period at a single university teaching hospital and reviewed their case notes.
Results: We excluded 58 of the 1598 patients on grounds of ineligibility (< 18 years of age and those transferred from other hospitals).